Table 2 Antipsychotic medication use
From: Microvascular dysfunction in schizophrenia: a case–control study
Antipsychotic | N (%) | Mean dose (mg) | s.d. | Mean duration (months) | s.d. |
|---|---|---|---|---|---|
Clozapine | 21 (41.2%) | 336.0 | 160.0 | 53.1 | 16.4 |
Risperidone | 11 (21.6%) | 2.9 | 1.4 | 38.6 | 25.2 |
Aripiprazole | 10 (19.6%) | 14.2 | 8.2 | 10.3 | 9.4 |
Olanzapine | 7 (13.7%) | 18.9 | 11.5 | 42.2 | 19.7 |
Quetiapine | 7 (13.7%) | 435.7 | 409.9 | 21.8 | 19.3 |
Paliperidone | 6 (11.8%) | 8.0 | 6.0 | 22.2 | 15.3 |
Ziprasidone | 4 (7.8%) | 67.5 | 18.9 | 29.8 | 18.4 |
Zuclophenthixol | 3 (5.9%) | 13.8 | 5.6 | 60 | n/a |
Asenapine | 1 (2.0%) | 5.0 | n/a | 3.0 | n/a |
Haloperidol | 1 (2.0%) | 2.0 | n/a | 60 | n/a |
Loxapine | 1 (2.0%) | n/a | n/a | n/a | n/a |
